Community pharmacy RSV expansion programme to be expanded four-fold The Department of Health and Social Care said up to 200 community pharmacy sites could be commissioned to provide the respiratory syncytial virus vaccination in 2025/2026.…
NHS England sets target to save £1bn on medicines by 2029 Board papers published in March 2025 said that using “commercial capabilities” had realised close to £500m in medicines savings in 2023/2024.…
NICE recommends capivasertib for advanced breast cancer Clinical trial results revealed that capivasertib, taken with fulvestrant, can provide advanced breast cancer patients with an additional four months before their cancer progresses.…
NHS England to assess feasibility of a national inhaler recycling scheme Health minister Karin Smyth said NHS England was “currently supporting the implementation of an inhaler recycling pilot to assess a national scheme’s feasibility and potential benefits”.…
Antidepressants added to PCN structured medication review list From 2025/2026, primary care networks are required to include people using antidepressants for structured medication reviews as part of medicines optimisation processes for “high-risk cohorts”.…
First UK joint asthma guidance: what does it mean for practice? In this episode of The PJ Pod, we explore the main changes and implications for practice brought about by the UK-wide joint asthma guideline.…
NHS England increases ARRS reimbursement for pharmacists in 2025/2026 The maximum reimbursable amount for Band 7–8a pharmacists employed under the Additional Roles Reimbursement Scheme will increase to £66,972.…
NICE approves first NHS treatment for advanced blood cancer Brentuximab combination therapy is a first-line treatment option for previously untreated stage 3 or 4 CD30-positive Hodgkin lymphoma that could benefit up to 800 people annually.…
NHS increases funding for inclisiran although uptake remains ‘slower than expected’ In a letter sent to colleagues, NHS England said it had increased the reimbursement fee for inclisiran from £50 to £60.…
Delivering advanced services under the new pharmacy contract Data obtained by The Pharmaceutical Journal show that one in ten pharmacies have withdrawn from an advanced service since 2021, but will the new funding make it easier for them to deliver these services?…
